Product Description
The global percutaneous transluminal angioplasty balloon market was valued at $558 million in 2025. This is expected to increase over the forecast period at a CAGR of 2.5% to reach nearly $663 million by 2032.
The full report on the global market for percutaneous transluminal angioplasty (PTA) balloons includes standard PTA balloon catheters, high-pressure PTA balloon catheters, large PTA balloon catheters, small PTA balloon catheters, and specialty PTA balloon catheters. Further unit analysis segmentation by application includes central venous/hemodialysis access, femoral-popliteal, iliac, infra-popliteal, renal, carotid, aorta, and other applications.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
PTA Balloon Market Trends
PTA balloons are largely commoditized products. Companies that sell high-priced atherectomy or adjunctive devices often significantly discount their balloons. This practice allows the company to profit from their high-margin sales, despite the price erosion for PTA balloons. Commoditization is especially apparent in the standard balloon market, which has the lowest ASP. Downward price trends, due to reimbursement restructuring, and low growth potential limit the appeal of the standard market for further investment. Nonetheless, there continues to be opportunity to develop small balloons and specialty products, such as cryoplasty, cutting and scoring balloons. These segments have higher growth rates and high ASPs.
PTA Balloon Market Share Insights
- Boston Scientific features key offerings in the standard balloon realm, notably the Mustang™ and Coyote™ balloon catheters. The company also holds a strong position in the emerging specialty PTA balloon segment with the Flextome™ Cutting Balloon™ Dilatation Device. In 2018, Boston Scientific’s acquisition of Cryterion Medical, previously an invested partner since 2016, added a single-shot cryoablation platform to its portfolio. Recently, in April 2025, Boston Scientific achieved CE mark approval for its POLARx FIT cryoballoon catheter for arterial fibrillation (AF) ablation.
- Becton Dickinson’s (BD) Conquest™ high-pressure balloon remains popular due to its strong performance among physicians. Intellectual property plays a pivotal role in this market, with BD holding crucial patents for high-pressure balloon technology. To navigate around patent constraints, competitors often develop balloons with thicker walls and a higher profile, which may compromise desirable low-profile characteristics. BD’s versatile Atlas® device, known for its low profile and high burst pressure, is adaptable across various procedure types. This offering is complemented by Dorado® and Conquest®, featuring higher rated burst pressures (RBPs) of 24 and 30 atmospheres, respectively.
- Medtronic’s Admiral Xtreme™, Evercross™ and Chocolate™ balloon catheters contributed significantly to its market dominance. The unique Chocolate™ balloon, designed with a nitinol cage for controlled dilatation, stands out by preventing dissection propagation through the creation of smaller dissections. Additionally, Medtronic’s RapidCross™, Reef™ and Amphirion™ Deep balloons expand its product portfolio across various categories within this segment.
PTA Balloon Market Segmentation Summary
- Standard PTA Balloon Catheter Market
- High-Pressure PTA Balloon Catheter Market
- Large PTA Balloon Catheter Market
- Small PTA Balloon Catheter Market
- Specialty PTA Balloon Catheter Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
